D20170327
De-identified Human Immune Atlas donor/sample detail for HCC_GSE140228_Cell_2019. The record preserves available public metadata while avoiding direct identifiers.
Primary Metadata
Core de-identified metadata fields migrated from the ImmuneAging donor manifest.
Donor ID
D20170327
Sample ID
D20170327-Blood-CD45+, D20170327-Blood-CD45+CD3+, D20170327-Normal-CD45+, D20170327-Normal-CD45+CD3+, D20170327-Tumor-CD45+, D20170327-Tumor-CD45+CD3+
Dataset
HCC_GSE140228_Cell_2019
Cohort
Chinese HCC immune-cell cohort, 10 donors
Age / Age Group
57 years
Sex
Male
Health Status
Hepatocellular carcinoma (HCC); HBV +; tumor stage IIIA
Tissue / Cell Source
blood; adjacent liver tissue; tumor tissue
Modality
scRNA-seq (Smart-seq2)
Cell Count
1,653
Analysis Status
Published scRNA-seq
UMAP Status
Ready
Metadata / Source Notes
Source patient ID: DSM27; Table S1 clinical characteristics: sex=Male, age=57 years, pathology=HCC, HBV=+, tumor stage=IIIA; Source: GEO GSE140228 processed metadata; PMID 31675496; platform: Smart-seq2; sample count: 6; tissues: Blood, Normal, Tumor; Donor UMAP PNG: IMG/umap/hcc-gse140228-cell-2019/donor/D20170327.png
Additional Clinical / Source Fields
Supplementary source metadata retained from the migrated manifest where available.
cancer type
Hepatocellular carcinoma
cancer type short
HCC
tnm stage
IIIA
bclc stage
Not provided
virus
HBV +
tumor size cm
Not provided
differentiation
Not provided
venous invasion
Not provided
cirrhosis
Not provided
afp ug l
Not provided
ca199 u ml
Not provided
cea ug l
Not provided
library count
6
library sample ids
D20170327-Blood-CD45+, D20170327-Blood-CD45+CD3+, D20170327-Normal-CD45+, D20170327-Normal-CD45+CD3+, D20170327-Tumor-CD45+, D20170327-Tumor-CD45+CD3+
total reads
Not provided
source reference
Zhang et al., Cell 179, 829-845.e20 (2019), Table S1 and GSE140228
data accession
GSE140228; HRA000069
article url